Mizuho Markets Americas LLC Grows Position in CVS Health Co. (NYSE:CVS)

Mizuho Markets Americas LLC boosted its stake in CVS Health Co. (NYSE:CVS) by 1,470.2% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,396,464 shares of the pharmacy operator’s stock after acquiring an additional 1,307,531 shares during the period. CVS Health comprises approximately 1.8% of Mizuho Markets Americas LLC’s investment portfolio, making the stock its 14th largest position. Mizuho Markets Americas LLC’s holdings in CVS Health were worth $87,810,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently bought and sold shares of the stock. Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health in the 3rd quarter valued at $32,000. First Community Trust NA lifted its stake in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. acquired a new position in CVS Health in the 3rd quarter valued at about $33,000. Finally, ORG Partners LLC lifted its position in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $53.19 on Friday. The company’s 50 day simple moving average is $59.23 and its 200-day simple moving average is $58.72. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25. The firm has a market cap of $66.93 billion, a PE ratio of 13.50, a price-to-earnings-growth ratio of 0.93 and a beta of 0.55. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period in the previous year, the business posted $2.21 earnings per share. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities analysts predict that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 5.00%. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

Wall Street Analyst Weigh In

Several brokerages have commented on CVS. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft decreased their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Truist Financial upped their target price on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research note on Friday, October 11th. UBS Group boosted their price target on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, Evercore ISI lifted their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $72.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.